Pain Management Clinical Trial
Official title:
Intrathecally Administered Ketamine, Dexmedetomidine, and Their Combination With Bupivacaine for Postoperative Analgesia in Major Abdominal Cancer Surgery
Currently, opioids are widely used for pain relief, but they often provide sub-optimal analgesia with occasional serious side effects. Preservative-free ketamine hydrochloride was introduced as a spinal anesthetic more than twenty years ago and found to have advantages over local anesthetics. Intrathecal dexmedetomidine provides an analgesic effect in postoperative pain without severe sedation. The objectives of this study were to compare the efficacy and safety of intrathecally administered dexmedetomidine, ketamine, or their combination when added to bupivacaine for postoperative analgesia in major abdominal cancer surgery.
This study was approved by the ethics committee of South Egypt Cancer Institute, Assiut
University, Assiut, Egypt. After obtaining a written informed consent, 90 American Society
of Anesthesia (ASA) I-II patients aged 30-50 years and scheduled for major abdominal cancer
surgery were included in the study. Patients with a known allergy to the study drugs,
significant cardiac, respiratory, renal or hepatic disease, coagulation disorder, infection
at the site of intrathecal injection, drug or alcohol abuse, BMI > 30 kg/m2 , and
psychiatric illnesses that would interfere with perception and assessment of pain were
excluded from the study.
Preoperatively, patients were taught how to evaluate their own pain intensity using the
visual analogue scale (VAS), scored from 0 -10 (where 0 = no pain, and 10 = the worst pain
imaginable).
Oral diazepam (5 mg) was taken the night before surgery. Up on arrival at the operative
theatre, a 16-gauge catheter was introduced intravenously at the dorsum of the hand;
lactated Ringer's solution 10 mg/kg was infused intravenously over 10 min. before initiation
of spinal anesthesia. Basic monitoring probes (electrocardiography, non invasive blood
pressure, O2 saturation, and temperature) were applied. Patients were placed in the setting
position and a 25-gauge Quincke needle was placed in the L2-3 or L3-4 interspaces.
Patients were randomly divided, by selecting sealed envelopes into one of three groups 30
patients each:
- The dexmedetomidine group (group I) received 10 mg of hyperbaric bupivacaine 0.5% in 2
ml volume and 5µg of dexmedetomidine in 1 ml volume intrathecally.
- The ketamine group (group II) received 10 mg of hyperbaric bupivacaine 0.5% in 2 ml
volume and 0.1 mg/kg ketamine in 1ml volume intrathecally.
- Dexmedetomidine + Ketamine group (group III) received 10 mg of hyperbaric bupivacaine
0.5% in 2 ml volume and 5µg of dexmedetomidine plus 0.1 mg/kg of Ketamine in 1 ml
volume intrathecally.
Immediately after their intrathecal injection, the patients were placed in the supine
position. After successful spinal anesthesia, general anesthesia was induced with fentanyl
1.5-2 µg/kg, propofol 2-3 mg/kg, and lidocaine 1.5 mg/kg. Endotracheal intubation was
facilitated by cis-atracurium 0.15 mg/kg. Heart rate, systolic, and diastolic blood pressure
were recorded at 5, 10, 20, 30, 60, 120, 180 minutes. Anesthesia and muscle relaxation were
maintained by isoflurane 1- 1.5 MAC in 50% oxygen/air mixture and cis-atracurium 0.03 mg/kg
bolus given every 30 min. respectively.
At the end of surgery, muscle relaxation was reversed by neostigmine 50 µg/kg and atropine
20 µg/kg. Patients were extubated and transferred to postanesthesia care unit (PACU) and
were monitored for vital signs (heart rate, non invasive blood pressure, respiratory rate,
and O2 saturation) immediately postoperative and at 2, 4, 6, 12, 18, and 24 hours
postoperative.
VAS scores were assessed at the same time points. Rescue analgesia represented by
patient-controlled analgesia (PCA) with intravenous morphine with an initial bolus of 0.1
mg/kg once pain was expressed by the patient, or if VAS was 3 or more (VAS ≥ 3) followed by
1 mg boluses with a lockout period of 5 min. The time of first request of analgesia and
total analgesic consumption in the first 24 hours postoperatively were recorded.
The patient's level of sedation was assessed at the same time points using a modified
Observer's Assessment of alertness/sedation (OAAS) scale (where 6 = agitated, and 0 =
doesn't respond to deep stimuls).
The attendant anesthesiologist, the patient-care giver, and the data collection personnel
were all blinded to patient assignment to a specific group. Postoperative adverse effects
such as nausea, vomiting, hypotension, bradycardia, cardiac arrhythmias were recorded and
treated.
Hypotension was defined as a 15% decrease in systolic blood pressure from baseline.
Bradycardia was defined as a heart rate slower than 50 beats per minute or a decrease in
heart rate of 20% or more from baseline; whichever is lowest. Hypoxia was defined as an
oxygen saturation of less than 90%. Hypotension was treated with intravenous boluse of
ephidrine 0.1 mg/kg and normal saline 5ml/kg; the same doses were repeated as required.
Bradycardia was treated with intravenous atropine 0.01 mg/kg.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03334929 -
Virtual Reality Distraction for Anxiety Reduction During Trigger Points Procedures in Pain Medicine Clinic
|
N/A | |
Recruiting |
NCT06129383 -
The Effect of Adding PIFP Block to SAP Block on Postoparative Pain Management in Patient Planned for Breast Surgery
|
N/A | |
Completed |
NCT06054945 -
Clinical Impact of IPACK Block Addition to Suprainguinal Fascia Iliaca Block
|
||
Active, not recruiting |
NCT02276495 -
Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty?
|
N/A | |
Completed |
NCT04094246 -
Battlefield Acupuncture Following Shoulder Surgery
|
N/A | |
Completed |
NCT05514236 -
Effect of Virtual Reality and Music Therapy on Pain Relief in Outpatient Hysteroscopy
|
N/A | |
Recruiting |
NCT04809935 -
EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy
|
Phase 4 | |
Not yet recruiting |
NCT05492903 -
COMmunity of Practice And Safety Support for Navigating Pain (COMPASS-NP)
|
N/A | |
Not yet recruiting |
NCT04328805 -
Pain Reduction and Changes in Upper Limb Function Produced by an Ibuprofen Treatment in Carpal Tunnel Syndrome.
|
Phase 4 | |
Completed |
NCT02922101 -
Evaluation of the Effectiveness of an Audit and Feedback Intervention With Quality Improvement Toolbox in Intensive Care
|
N/A | |
Completed |
NCT01541293 -
Intrauterine Lidocaine for Laminaria
|
Phase 1 | |
Not yet recruiting |
NCT01059487 -
Bringing Acute and Wellness Care to Underserved Populations Using Traditional Chinese Medicine
|
Phase 0 | |
Completed |
NCT03290378 -
Tramadol Versus Placebo in the Management of Postoperative Pain Following Bunionectomy
|
Phase 3 | |
Recruiting |
NCT05794828 -
Erector Spinae Regional Anesthesia for Pain Control
|
Early Phase 1 | |
Active, not recruiting |
NCT04109885 -
Paracervical Injection for Headache in the Emergency Department
|
Phase 2 | |
Recruiting |
NCT05857202 -
Oxidative Stress and Inflammation Biomarkers in Surgically Treated Patients With Laryngeal Cancer
|
||
Recruiting |
NCT03851042 -
Virtual Reality for Postoperative Pain After Laparoscopic Hysterectomy
|
N/A | |
Completed |
NCT04566536 -
NoL Monitor Performances of Nociceptive and Non-nociceptive Stimuli Discrimination During Robotic Surgery
|
||
Completed |
NCT03471390 -
Improving Pain Management in Nursing Homes: a Pilot Study
|
N/A | |
Enrolling by invitation |
NCT02995278 -
Usage and Plan of Care Changes Due to Drug Screenings
|